Bausch + Lomb and Clearside Biomedical Announce U.S. FDA Filing Acceptance for XIPERE

Bausch + Lomb, along with Clearside Biomedical, a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension). FDA determined that the filing is a Class 2 resubmission and therefore assigned a Prescription Drug User Fee Act (PDUFA) action date of October 30, 2021. XIPERE is an investigational therapy with a proposed indication of treatment of macular edema associated with uveitis.

According to the company, Bausch + Lomb has the exclusive license for the commercialization and development of XIPERE in the United States and Canada.

“If approved by the FDA, XIPERE would be the first therapy available utilizing the suprachoroidal space for patients suffering from macular edema associated with uveitis, which is the leading cause of vision loss in people with uveitis,” said Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb.

“XIPERE has the potential to advance the care of people suffering from macular edema with uveitis,” said George Lasezkay, Pharm.D., J.D., president and CEO, Clearside. “If approved, XIPERE would be our first commercial product and the first approved drug to be delivered into the suprachoroidal space (SCS®).”

XIPERE is designed for suprachoroidal administration via Clearside’s patented, proprietary SCS Microinjector® that offers unprecedented access to the back of the eye where sight-threatening disease often occurs.

Click HERE for the full press release.

Featured Posts

EssilorLuxottica Board of Directors Pays Tribute to Leonardo Del Vecchio, Appoints New Chairman

EssilorLuxottica’s Board of Directors met today and paid homage to Chairman, Leonardo Del Vecchio, who passed away peacefully yesterday morning.

Learn More

CooperVision Research at NCC Elevates Clinical Care

Scientists Share New Findings in Presbyopia, Astigmatism, Myopia Management, and More

Read more

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Read more

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read more

EssilorLuxottica Board of Directors Pays Tribute to Leonardo Del Vecchio, Appoints New Chairman

EssilorLuxottica’s Board of Directors met today and paid homage to Chairman, Leonardo Del Vecchio, who passed away peacefully yesterday morning.

Learn More

CooperVision Research at NCC Elevates Clinical Care

Scientists Share New Findings in Presbyopia, Astigmatism, Myopia Management, and More

Read More

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Read More

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read More

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read More

EssilorLuxottica Board of Directors Pays Tribute to Leonardo Del Vecchio, Appoints New Chairman

EssilorLuxottica’s Board of Directors met today and paid homage to Chairman, Leonardo Del Vecchio, who passed away peacefully yesterday morning.

Learn More

CooperVision Research at NCC Elevates Clinical Care

Scientists Share New Findings in Presbyopia, Astigmatism, Myopia Management, and More

Read more

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Read more

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read more

EssilorLuxottica Board of Directors Pays Tribute to Leonardo Del Vecchio, Appoints New Chairman

EssilorLuxottica’s Board of Directors met today and paid homage to Chairman, Leonardo Del Vecchio, who passed away peacefully yesterday morning.

Learn More

CooperVision Research at NCC Elevates Clinical Care

Scientists Share New Findings in Presbyopia, Astigmatism, Myopia Management, and More

Read more

The Optical Metaverse

My Vision Show, the innovative platform that has provided thousands of eye care professionals a more accessible way to view and participate in live stream events has now taken their program to the next level.

Read more

EssilorLuxottica Announce Its Chairman Leonardo Del Vecchio Has Passed Away

The Company expresses its deepest condolences to the Family and to the global employee community for this enormous loss.

Read more

Transitions Appoints Mathieu Arsenault as Channel Marketing Manager, Canada

In this role, Arsenault will oversee responsibilities including developing and implementing key account marketing strategies that align with retailers and partners in Canada to build the Transitions® business, planning and managing consumer marketing and many more leading key initiatives.

Read more